CN Stock MarketDetailed Quotes

300529 Jafron Biomedical

Watchlist
  • 25.85
  • -0.15-0.58%
Market Closed Aug 16 15:00 CST
20.87BMarket Cap29.34P/E (TTM)

Jafron Biomedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
47.77%1.5B
30.00%744.34M
-22.84%1.92B
-26.64%1.49B
-34.88%1.01B
-17.90%572.56M
-6.88%2.49B
13.69%2.03B
30.80%1.55B
20.46%697.36M
Operating revenue
47.77%1.5B
30.00%744.34M
-22.84%1.92B
-26.64%1.49B
-34.88%1.01B
-17.90%572.56M
-6.88%2.49B
13.69%2.03B
30.80%1.55B
20.46%697.36M
Other operating revenue
222.73%4.53M
----
-24.74%3.42M
----
29.57%1.4M
----
0.93%4.54M
----
-13.68%1.08M
----
Total operating cost
22.05%861.39M
20.39%421.94M
-8.35%1.42B
-4.87%1.01B
-3.00%705.76M
11.51%350.49M
16.29%1.55B
29.75%1.07B
46.81%727.58M
25.11%314.32M
Operating cost
47.87%291.11M
41.52%158.66M
-12.75%383.98M
-15.14%287.35M
-21.85%196.86M
3.74%112.11M
9.46%440.11M
26.28%338.6M
43.93%251.89M
26.36%108.06M
Operating tax surcharges
52.64%23.97M
37.04%11.67M
-9.28%31.82M
-17.71%23.41M
-29.58%15.71M
-22.55%8.51M
-12.41%35.07M
6.97%28.45M
26.51%22.3M
28.13%10.99M
Operating expense
5.31%340.76M
1.00%158.5M
-12.08%615.97M
-4.46%441.05M
6.31%323.58M
26.13%156.94M
17.07%700.63M
26.14%461.66M
38.80%304.37M
10.08%124.43M
Administration expense
16.13%84.67M
39.32%38.47M
28.40%177.39M
22.60%112.65M
16.30%72.91M
-5.14%27.61M
5.48%138.15M
13.88%91.88M
34.02%62.69M
7.05%29.11M
Financial expense
145.20%8.1M
105.47%476.36K
-90.21%-33.9M
-57.89%-26.85M
-32.70%-17.91M
-1,009.28%-8.71M
-43.27%-17.82M
-6.02%-17M
5.41%-13.5M
123.95%957.75K
-Interest expense (Financial expense)
29.07%32.56M
33.49%16.35M
50.74%54.33M
171.94%40.29M
156.73%25.23M
151.53%12.25M
304.60%36.04M
246.51%14.82M
3,060.84%9.83M
--4.87M
-Interest Income (Financial expense)
43.46%-24.54M
27.08%-15.65M
-65.15%-87.96M
-77.87%-67M
-62.99%-43.41M
-247.18%-21.46M
-91.63%-53.26M
-84.07%-37.67M
-70.16%-26.63M
-29.11%-6.18M
Research and development
-1.60%112.79M
0.27%54.17M
-3.36%245.38M
8.67%176.36M
14.82%114.62M
32.50%54.02M
46.12%253.91M
68.86%162.28M
95.09%99.82M
95.03%40.77M
Credit Impairment Loss
-299.36%-7.91M
-264.19%-1.28M
320.33%8.23M
130.26%2.45M
151.83%3.97M
115.65%777.07K
130.33%1.96M
-4.30%-8.09M
-52.12%-7.66M
-12.87%-4.97M
Asset Impairment Loss
----
--0
-332.78%-28.18M
--0
--0
--0
-11,345.79%-6.51M
--0
--0
--0
Other net revenue
29.01%42.75M
53.85%26.32M
-52.18%42.11M
-30.19%43.12M
-37.89%33.14M
59.40%17.11M
16.84%88.06M
15.11%61.76M
37.78%53.35M
52.34%10.73M
Fair value change income
--5.8M
--1.01M
--0
--0
--0
--0
-200.00%-14.99K
---14.99K
---14.99K
---14.99K
Invest income
--8.18M
--2.53M
--0
--0
----
--0
-63.34%10.52M
-39.61%10.48M
-22.32%9.66M
36.80%10.69M
Asset deal income
-64.28%2.16M
-76.75%1.28M
677.04%6.72M
1,039.72%5.92M
1,268.35%6.06M
2,659.55%5.5M
-12.01%864.77K
-7.14%519.06K
43.18%442.64K
--199.14K
Other revenue
49.37%34.52M
110.20%22.78M
-31.87%55.35M
-40.97%34.76M
-54.62%23.11M
124.41%10.83M
55.69%81.24M
35.33%58.88M
64.18%50.93M
32.90%4.83M
Operating profit
99.39%676.98M
45.80%348.72M
-47.17%543.82M
-49.58%515.13M
-61.42%339.52M
-39.26%239.18M
-27.40%1.03B
0.75%1.02B
20.33%880.06M
17.64%393.77M
Add:Non operating Income
-59.57%99.45K
-62.65%62.17K
-13.26%322.34K
56.21%319.56K
81.86%246.02K
288.79%166.45K
-51.91%371.63K
-70.00%204.58K
-74.35%135.28K
-68.97%42.81K
Less:Non operating expense
57.22%16.83M
15.36%8.84M
77.61%23.12M
184.17%16.56M
256.16%10.71M
1,072.82%7.67M
13.41%13.02M
-4.07%5.83M
12.70%3.01M
71.24%653.73K
Total profit
100.65%660.25M
46.73%339.93M
-48.76%521.02M
-50.90%498.89M
-62.49%329.06M
-41.07%231.68M
-27.74%1.02B
0.73%1.02B
20.29%877.19M
17.54%393.16M
Less:Income tax cost
103.29%109.5M
53.74%56.01M
-29.86%95.3M
-46.58%78.45M
-58.94%53.86M
-38.01%36.43M
-35.72%135.86M
0.24%146.87M
19.06%131.18M
13.69%58.77M
Net profit
100.13%550.76M
45.42%283.93M
-51.67%425.72M
-51.62%420.44M
-63.11%275.2M
-41.61%195.25M
-26.33%880.95M
0.82%869.1M
20.51%746.01M
18.25%334.39M
Net profit from continuing operation
100.13%550.76M
45.42%283.93M
-51.67%425.72M
-51.62%420.44M
-63.11%275.2M
-41.61%195.25M
-26.33%880.95M
0.82%869.1M
20.51%746.01M
18.25%334.39M
Less:Minority Profit
24.08%-1.75M
34.49%-837.96K
-24.94%-10.77M
25.96%-3.22M
-7.31%-2.31M
-56.54%-1.28M
-786.84%-8.62M
-325.93%-4.35M
-97.33%-2.15M
-56.68%-817.14K
Net profit of parent company owners
99.10%552.51M
44.90%284.77M
-50.93%436.49M
-51.50%423.66M
-62.91%277.51M
-41.37%196.53M
-25.67%889.56M
1.20%873.45M
20.64%748.16M
18.32%335.21M
Earning per share
Basic earning per share
97.14%0.69
42.76%0.3512
-50.89%0.55
-51.82%0.53
-62.37%0.35
-41.43%0.246
-24.83%1.12
1.85%1.1
19.23%0.93
20.00%0.42
Diluted earning per share
100.00%0.68
44.00%0.3495
-49.56%0.57
-51.85%0.52
-63.44%0.34
-40.80%0.2427
-24.16%1.13
0.93%1.08
20.78%0.93
17.14%0.41
Other composite income
181.20%26.93M
0
-3,304.61%-33.17M
1.81M
1.81M
0
Other composite income of parent company owners
----
----
181.20%26.93M
--0
----
----
-3,304.61%-33.17M
--1.81M
--1.81M
--0
Total composite income
100.13%550.76M
45.42%283.93M
-46.61%452.65M
-51.72%420.44M
-63.20%275.2M
-41.61%195.25M
-29.17%847.78M
1.03%870.91M
20.80%747.82M
18.25%334.39M
Total composite income of parent company owners
99.10%552.51M
44.90%284.77M
-45.89%463.42M
-51.60%423.66M
-63.00%277.51M
-41.37%196.53M
-28.51%856.4M
1.41%875.26M
20.93%749.97M
18.32%335.21M
Total composite income of minority owners
24.08%-1.75M
34.49%-837.96K
-24.94%-10.77M
25.96%-3.22M
-7.31%-2.31M
-56.54%-1.28M
-786.84%-8.62M
-325.93%-4.35M
-97.33%-2.15M
-56.68%-817.14K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 47.77%1.5B30.00%744.34M-22.84%1.92B-26.64%1.49B-34.88%1.01B-17.90%572.56M-6.88%2.49B13.69%2.03B30.80%1.55B20.46%697.36M
Operating revenue 47.77%1.5B30.00%744.34M-22.84%1.92B-26.64%1.49B-34.88%1.01B-17.90%572.56M-6.88%2.49B13.69%2.03B30.80%1.55B20.46%697.36M
Other operating revenue 222.73%4.53M-----24.74%3.42M----29.57%1.4M----0.93%4.54M-----13.68%1.08M----
Total operating cost 22.05%861.39M20.39%421.94M-8.35%1.42B-4.87%1.01B-3.00%705.76M11.51%350.49M16.29%1.55B29.75%1.07B46.81%727.58M25.11%314.32M
Operating cost 47.87%291.11M41.52%158.66M-12.75%383.98M-15.14%287.35M-21.85%196.86M3.74%112.11M9.46%440.11M26.28%338.6M43.93%251.89M26.36%108.06M
Operating tax surcharges 52.64%23.97M37.04%11.67M-9.28%31.82M-17.71%23.41M-29.58%15.71M-22.55%8.51M-12.41%35.07M6.97%28.45M26.51%22.3M28.13%10.99M
Operating expense 5.31%340.76M1.00%158.5M-12.08%615.97M-4.46%441.05M6.31%323.58M26.13%156.94M17.07%700.63M26.14%461.66M38.80%304.37M10.08%124.43M
Administration expense 16.13%84.67M39.32%38.47M28.40%177.39M22.60%112.65M16.30%72.91M-5.14%27.61M5.48%138.15M13.88%91.88M34.02%62.69M7.05%29.11M
Financial expense 145.20%8.1M105.47%476.36K-90.21%-33.9M-57.89%-26.85M-32.70%-17.91M-1,009.28%-8.71M-43.27%-17.82M-6.02%-17M5.41%-13.5M123.95%957.75K
-Interest expense (Financial expense) 29.07%32.56M33.49%16.35M50.74%54.33M171.94%40.29M156.73%25.23M151.53%12.25M304.60%36.04M246.51%14.82M3,060.84%9.83M--4.87M
-Interest Income (Financial expense) 43.46%-24.54M27.08%-15.65M-65.15%-87.96M-77.87%-67M-62.99%-43.41M-247.18%-21.46M-91.63%-53.26M-84.07%-37.67M-70.16%-26.63M-29.11%-6.18M
Research and development -1.60%112.79M0.27%54.17M-3.36%245.38M8.67%176.36M14.82%114.62M32.50%54.02M46.12%253.91M68.86%162.28M95.09%99.82M95.03%40.77M
Credit Impairment Loss -299.36%-7.91M-264.19%-1.28M320.33%8.23M130.26%2.45M151.83%3.97M115.65%777.07K130.33%1.96M-4.30%-8.09M-52.12%-7.66M-12.87%-4.97M
Asset Impairment Loss ------0-332.78%-28.18M--0--0--0-11,345.79%-6.51M--0--0--0
Other net revenue 29.01%42.75M53.85%26.32M-52.18%42.11M-30.19%43.12M-37.89%33.14M59.40%17.11M16.84%88.06M15.11%61.76M37.78%53.35M52.34%10.73M
Fair value change income --5.8M--1.01M--0--0--0--0-200.00%-14.99K---14.99K---14.99K---14.99K
Invest income --8.18M--2.53M--0--0------0-63.34%10.52M-39.61%10.48M-22.32%9.66M36.80%10.69M
Asset deal income -64.28%2.16M-76.75%1.28M677.04%6.72M1,039.72%5.92M1,268.35%6.06M2,659.55%5.5M-12.01%864.77K-7.14%519.06K43.18%442.64K--199.14K
Other revenue 49.37%34.52M110.20%22.78M-31.87%55.35M-40.97%34.76M-54.62%23.11M124.41%10.83M55.69%81.24M35.33%58.88M64.18%50.93M32.90%4.83M
Operating profit 99.39%676.98M45.80%348.72M-47.17%543.82M-49.58%515.13M-61.42%339.52M-39.26%239.18M-27.40%1.03B0.75%1.02B20.33%880.06M17.64%393.77M
Add:Non operating Income -59.57%99.45K-62.65%62.17K-13.26%322.34K56.21%319.56K81.86%246.02K288.79%166.45K-51.91%371.63K-70.00%204.58K-74.35%135.28K-68.97%42.81K
Less:Non operating expense 57.22%16.83M15.36%8.84M77.61%23.12M184.17%16.56M256.16%10.71M1,072.82%7.67M13.41%13.02M-4.07%5.83M12.70%3.01M71.24%653.73K
Total profit 100.65%660.25M46.73%339.93M-48.76%521.02M-50.90%498.89M-62.49%329.06M-41.07%231.68M-27.74%1.02B0.73%1.02B20.29%877.19M17.54%393.16M
Less:Income tax cost 103.29%109.5M53.74%56.01M-29.86%95.3M-46.58%78.45M-58.94%53.86M-38.01%36.43M-35.72%135.86M0.24%146.87M19.06%131.18M13.69%58.77M
Net profit 100.13%550.76M45.42%283.93M-51.67%425.72M-51.62%420.44M-63.11%275.2M-41.61%195.25M-26.33%880.95M0.82%869.1M20.51%746.01M18.25%334.39M
Net profit from continuing operation 100.13%550.76M45.42%283.93M-51.67%425.72M-51.62%420.44M-63.11%275.2M-41.61%195.25M-26.33%880.95M0.82%869.1M20.51%746.01M18.25%334.39M
Less:Minority Profit 24.08%-1.75M34.49%-837.96K-24.94%-10.77M25.96%-3.22M-7.31%-2.31M-56.54%-1.28M-786.84%-8.62M-325.93%-4.35M-97.33%-2.15M-56.68%-817.14K
Net profit of parent company owners 99.10%552.51M44.90%284.77M-50.93%436.49M-51.50%423.66M-62.91%277.51M-41.37%196.53M-25.67%889.56M1.20%873.45M20.64%748.16M18.32%335.21M
Earning per share
Basic earning per share 97.14%0.6942.76%0.3512-50.89%0.55-51.82%0.53-62.37%0.35-41.43%0.246-24.83%1.121.85%1.119.23%0.9320.00%0.42
Diluted earning per share 100.00%0.6844.00%0.3495-49.56%0.57-51.85%0.52-63.44%0.34-40.80%0.2427-24.16%1.130.93%1.0820.78%0.9317.14%0.41
Other composite income 181.20%26.93M0-3,304.61%-33.17M1.81M1.81M0
Other composite income of parent company owners --------181.20%26.93M--0---------3,304.61%-33.17M--1.81M--1.81M--0
Total composite income 100.13%550.76M45.42%283.93M-46.61%452.65M-51.72%420.44M-63.20%275.2M-41.61%195.25M-29.17%847.78M1.03%870.91M20.80%747.82M18.25%334.39M
Total composite income of parent company owners 99.10%552.51M44.90%284.77M-45.89%463.42M-51.60%423.66M-63.00%277.51M-41.37%196.53M-28.51%856.4M1.41%875.26M20.93%749.97M18.32%335.21M
Total composite income of minority owners 24.08%-1.75M34.49%-837.96K-24.94%-10.77M25.96%-3.22M-7.31%-2.31M-56.54%-1.28M-786.84%-8.62M-325.93%-4.35M-97.33%-2.15M-56.68%-817.14K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg